ANDA 87932, held by Ambix. Triamcinolone Acetonide.
As of Nov 15, 2026, ANDA 87932 (Triamcinolone Acetonide), held by Ambix, was first approved by FDA on May 9, 1983, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 9, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Triamcinolone Acetonide0.025% ยท cream;topical | Triamcinolone Acetonide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
